Protein A - 50nm Gold NanoUrchins
Cytodiagnostics
SKU:GUAC-50-05-05
Couldn't load pickup availability

Protein A - 50nm Gold NanoUrchins for NanoUrchin-based assays
Protein A - 50nm Gold NanoUrchins is a gold NanoUrchin conjugate for detecting compatible immunoglobulins through Protein A binding in Immunoblotting, Light Microscopy and Electron Microscopy. It helps researchers evaluate target fit, assay readout and control strategy before selecting a related label or antibody format.
Scientific fit
Its NanoUrchin morphology supports red-shifted plasmon behavior and enhanced optical response compared with spherical particles of similar core size. This smaller NanoUrchin format is helpful when particle access and optical response both matter in compact assay geometries.
Protocol notes
- Supports Immunoblotting, Light Microscopy and Electron Microscopy workflows where Protein A signal needs to be interpreted with appropriate controls.
- Useful when the primary antibody class is compatible with Protein A binding and a species-independent detection strategy is desired.
- Include matched negative controls and optimize blocking to separate true target-associated signal from nonspecific particle binding.
Reference GUAC-50-05-05 in protocols, purchasing notes and internal reagent libraries when matching this product to your chosen assay. For reproducible work, document the selected reagent, sample matrix and detection workflow alongside the catalog entry.
- Research Area:
- Bioconjugation & Labeling • Assay Development • Nanotechnology & Biosensors
- Application:
- Immunoblotting • Light Microscopy • Electron Microscopy
- Host:
- S. Aureus
- Formulation:
- 0.5XPBS (pH 7.4), 20% glycerol (v/v), 1% BSA
- Adsorption Max:
- 560nm
- Core Size:
- 50nm
- Shape:
- Urchin
- Material:
- Gold
- Storage Temperature:
- 4°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.